200 related articles for article (PubMed ID: 31418623)
1. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
2. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in Autoimmune Retinopathy Patients Treated With Rituximab.
Davoudi S; Ebrahimiadib N; Yasa C; Sevgi DD; Roohipoor R; Papavasilieou E; Comander J; Sobrin L
Am J Ophthalmol; 2017 Aug; 180():124-132. PubMed ID: 28483493
[TBL] [Abstract][Full Text] [Related]
4. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
[No Abstract] [Full Text] [Related]
5. Slowly progressive non-neoplastic autoimmune-like retinopathy.
Ohta K; Kikuchi T; Yoshida N
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
[No Abstract] [Full Text] [Related]
6. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.
Boudreault K; Justus S; Sengillo JD; Schuerch K; Lee W; Cabral T; Tsang SH
Orphanet J Rare Dis; 2017 Jul; 12(1):129. PubMed ID: 28709429
[TBL] [Abstract][Full Text] [Related]
8. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
9. Retinal anti-bipolar cell antibodies in a patient with paraneoplastic retinopathy and colon carcinoma.
Jacobson DM; Adamus G
Am J Ophthalmol; 2001 Jun; 131(6):806-8. PubMed ID: 11384586
[TBL] [Abstract][Full Text] [Related]
10. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
[TBL] [Abstract][Full Text] [Related]
11. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report.
Eton EA; Abrams G; Khan NW; Fahim AT
BMC Ophthalmol; 2020 Apr; 20(1):153. PubMed ID: 32299429
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
Oporto Caroca JI; Oporto Caroca J
Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
[TBL] [Abstract][Full Text] [Related]
14. NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT.
Garcia CM; Maleki A; Look-Why S; Manhapra A; Durrani K; Foster CS
Retin Cases Brief Rep; 2023 Jul; 17(4):384-388. PubMed ID: 34618714
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography findings in autoimmune retinopathy.
Abazari A; Allam SS; Adamus G; Ghazi NG
Am J Ophthalmol; 2012 Apr; 153(4):750-6, 756.e1. PubMed ID: 22245461
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression for autoimmune retinopathy.
Jampol LM; Fishman GA
Arch Ophthalmol; 2009 Apr; 127(4):573-5. PubMed ID: 19365043
[No Abstract] [Full Text] [Related]
17. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
18. Antiretinal antibody- proven autoimmune retinopathy.
Abraham S; Sudharshan S; Bhende M; Ganesh SK; Gopal S
Indian J Ophthalmol; 2017 May; 65(5):416-420. PubMed ID: 28574003
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
[TBL] [Abstract][Full Text] [Related]
20. Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy.
Maleki A; Colombo A; Look-Why S; Peter Y Chang BA; Anesi SD; Anesi SD
J Ophthalmic Vis Res; 2022; 17(4):515-528. PubMed ID: 36620716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
